HANDLE-a Real World Study on Satralizumab in NMOSD
NCT06829524
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Interventions
DRUG:
Satralizumab
Sponsor
Huashan Hospital